Repligen (RGEN) EV to EBITDA (2011 - 2026)
Repligen's EV to EBITDA came in at 48.04 for Q2 2026, down 61.3% from 123.98 a year earlier but up 18.3% from the prior quarter.
Powered by 
Analysis
Repligen (RGEN) EV to EBITDA (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Repligen reported EV to EBITDA of 31.99, down 59.9% year-over-year; for FY2025, it was 63.19, down 70.2% from FY2024.
- Going back by year, EV to EBITDA was 211.71 in FY2024 (+165.4%), 79.78 in FY2023 (+150.4%), 31.86 in FY2022 (-53.3%) and 68.29 in FY2021 (-32.3%).
- The five-year range for quarterly EV to EBITDA is 31.86 (Q4 2022) to 211.71 (Q4 2024).
- Year-over-year, EV to EBITDA has declined for four consecutive quarters, with growth averaging 25.1% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in Q4 2024 (growth of 165.4%), and the weakest in Q1 2026 (a decline of 75.3%).
- Business Quant data shows RGEN's EV to EBITDA at 40.60 (Q1 2026), 63.19 (Q4 2025) and 86.90 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn |
| 10 | Repligen | 10.16 Bn | 7.05 Bn | 110.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.86 |
| Mar 31, 2026 | 36.33 |
| Dec 31, 2025 | 56.20 |
| Sep 30, 2025 | 71.86 |
| Jun 30, 2025 | 94.22 |
| Mar 31, 2025 | 117.29 |
| Dec 31, 2024 | 145.90 |
| Sep 30, 2024 | 81.64 |
| Jun 30, 2024 | 59.97 |
| Mar 31, 2024 | 83.62 |
| Dec 31, 2023 | 78.14 |
| Sep 30, 2023 | 53.43 |
| Jun 30, 2023 | 37.35 |
| Mar 31, 2023 | 37.26 |
| Dec 31, 2022 | 31.65 |
| Sep 30, 2022 | 37.01 |
| Jun 30, 2022 | 32.66 |
| Mar 31, 2022 | 40.69 |
| Dec 31, 2021 | 64.67 |
| Sep 30, 2021 | 79.34 |
API Access
Repligen EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "RGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();